263 related articles for article (PubMed ID: 24759599)
1. Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.
Zimmermann S; Dziadziuszko R; Peters S
Cancer Treat Rev; 2014 Jul; 40(6):716-22. PubMed ID: 24759599
[TBL] [Abstract][Full Text] [Related]
2. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.
Namba Y; Kijima T; Yokota S; Niinaka M; Kawamura S; Iwasaki T; Takeda Y; Kimura H; Okada T; Yamaguchi T; Nakagawa M; Okumura Y; Maeda H; Ito M
Clin Lung Cancer; 2004 Sep; 6(2):123-8. PubMed ID: 15476598
[TBL] [Abstract][Full Text] [Related]
3. [The boundaries of curation].
Debus J; Eberhardt W; Hoffmann H; Passlick B; Rübe C; Thomas M
Onkologie; 2010; 33 Suppl 5():12-20. PubMed ID: 20523102
[TBL] [Abstract][Full Text] [Related]
4. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
[TBL] [Abstract][Full Text] [Related]
5. Treatment of brain metastases from lung cancer: chemotherapy.
Schuette W
Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
[TBL] [Abstract][Full Text] [Related]
6. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases.
Girard N; Cottin V; Tronc F; Etienne-Mastroianni B; Thivolet-Bejui F; Honnorat J; Guyotat J; Souquet PJ; Cordier JF
Lung Cancer; 2006 Jul; 53(1):51-8. PubMed ID: 16730853
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.
Park SJ; Kim HT; Lee DH; Kim KP; Kim SW; Suh C; Lee JS
Lung Cancer; 2012 Sep; 77(3):556-60. PubMed ID: 22677429
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.
Jamal-Hanjani M; Spicer J
Clin Cancer Res; 2012 Feb; 18(4):938-44. PubMed ID: 22167408
[TBL] [Abstract][Full Text] [Related]
11. [Research progress of targeted therapy in non-small cell lung cancer brain metastases].
Jiang T; Zhou C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):824-8. PubMed ID: 25404274
[TBL] [Abstract][Full Text] [Related]
12. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases in small cell lung cancer.
Quan AL; Videtic GM; Suh JH
Oncology (Williston Park); 2004 Jul; 18(8):961-72; discussion 974, 979-80, 987. PubMed ID: 15328892
[TBL] [Abstract][Full Text] [Related]
15. The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer.
Laskin JJ; Sandler AB
Clin Adv Hematol Oncol; 2003 Dec; 1(12):731-34. PubMed ID: 16258477
[TBL] [Abstract][Full Text] [Related]
16. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
Socinski MA; Langer CJ; Huang JE; Kolb MM; Compton P; Wang L; Akerley W
J Clin Oncol; 2009 Nov; 27(31):5255-61. PubMed ID: 19738122
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib in non-small cell lung cancer treatment: current status and future development.
Gridelli C; Bareschino MA; Schettino C; Rossi A; Maione P; Ciardiello F
Oncologist; 2007 Jul; 12(7):840-9. PubMed ID: 17673615
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.
Chiu CH; Tsai CM; Chen YM; Chiang SC; Liou JL; Perng RP
Lung Cancer; 2005 Jan; 47(1):129-38. PubMed ID: 15603863
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients excluded from Eastern Cooperative Oncology Group 4599 and AVAiL studies: focus on brain metastasis and squamous histology.
Morgensztern D; Govindan R
Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S57-61. PubMed ID: 21885000
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival following concurrent chemoradiotherapy in patients with non-small-cell lung cancer with concomitant brain metastases only.
Harita S; Mizuta A; Kuyama S; Kikuchi T
Int J Clin Oncol; 2005 Feb; 10(1):63-8. PubMed ID: 15729604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]